亚太地区高流量鼻插管市场至 2027 年 - 按组件(空气氧混合器、鼻插管、加热吸气回路和主动加湿器)进行区域分析和预测;应用(支气管扩张、急性呼吸衰竭、急性心力衰竭、慢性阻塞性肺疾病);最终用户(门诊护理中心、医院和长期护理中心)和国家/地区

Historic Data: 2016-2017   |   Base Year: 2018   |   Forecast Period: 2019-2027


No. of Pages: 129    |    Report Code: TIPRE00008094    |    Category: Life Sciences

Asia-Pacific High-Flow Nasal Cannula Market

亚太高流量鼻插管市场预计

将达到25.3652亿美元预计到 2027 年,该市场的规模将从 2018 年的 9.5153 亿美元增长到 2027 年。预计 2019 年至 2027 年,该市场将以 11.7% 的复合年增长率增长。

 

推动高流量鼻插管市场增长的关键因素是亚太地区老年人口的增长和慢性呼吸道疾病的增加。然而,限制市场增长的因素是高流量鼻插管的后遗症。

 

根据 NCD 联盟的数据,慢性呼吸道疾病疾病(CRD)描述了一系列气道和肺部其他结构的疾病。哮喘和呼吸道过敏、职业性肺病、慢性阻塞性肺病(COPD)、睡眠呼吸暂停综合征和肺动脉高压只是其中的少数。亚太地区所有国家的慢性呼吸道疾病 (CRD) 负担都在增加。根据《柳叶刀全球健康》发表的文章,印度人口占全球人口的 18%,慢性呼吸道疾病的负担日益增加。

                       

与其他国家相比,印度的哮喘患病率明显较高。据估计,印度有 15 至 2000 万哮喘患者,其中至少十分之一的哮喘患者生活在印度。据世界卫生组织估计,大约有3000万印度人患有哮喘。印度哮喘病例数上升的一些常见因素包括肥胖、吸烟、室内外空气污染、突然过度使用或滥用抗生素、花粉、二手烟、家庭和工作场所通风不良等。除了哮喘之外,慢性阻塞性肺病病例的增加也引起了该国的关注。根据华盛顿大学 2018 年全球疾病负担研究,慢性阻塞性肺病是印度第二大死因,导致近 958,000 人死亡。

 < /p>

2027 年印度高流量鼻插管市场收入及预测(百万美元)



欧洲高流量鼻插管市场 –按组件

  • 空气氧气混合器
  • 鼻插管
  • 加热吸气回路
  • 主动加湿器

欧洲高流量鼻插管市场 –按应用

  • 支气管扩张
  • 急性呼吸衰竭
  • < li>急性心力衰竭
  • 慢性阻塞性肺疾病(COPD)

欧洲高流量鼻插管市场 –按最终用户

  • 医院
  • 门诊护理中心
  • 长期护理中心

欧洲高流量鼻插管市场

国家/地区

  • 亚太地区


    • 中国
    • 日本
    • 印度< /li>
    • 澳大利亚
    • 韩国

< span>

提及公司

  • 格瑞集团医疗股份有限公司
  • Salter Labs
  • Fisher And Paykel Healthcare Limited
  • TNI Medical Ag
  • < span>Mek-Ics股份有限公司
  • Flexicare Medical Limited
  • Vapotherm
  • 泰利福公司
  • 瑞思迈
  • 汉密尔顿医疗公司
  • < /ul>

    Asia-Pacific High-Flow Nasal Cannula Strategic Insights

    Strategic insights for Asia-Pacific High-Flow Nasal Cannula involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

    strategic-framework/asia-pacific-high-flow-nasal-cannula-market-strategic-framework.webp
    Get more information on this report

    Asia-Pacific High-Flow Nasal Cannula Report Scope

    Report Attribute Details
    Market size in 2018 US$ 951.53 Million
    Market Size by 2027 US$ 2,536.52 Million
    Global CAGR (2019 - 2027) 11.7%
    Historical Data 2016-2017
    Forecast period 2019-2027
    Segments Covered By 组件
    • 空气氧气混合器
    • 鼻插管
    • 加热吸气回路
    • 主动加湿器
    By 应用
    • 支气管扩张
    • 急性呼吸衰竭
    • 急性心力衰竭
    • 慢性阻塞性肺病
    By 最终用户
    • 门诊护理中心
    • 医院和长期护理中心
    Regions and Countries Covered 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 亚太其他地区
    Market leaders and key company profiles
  • Great Group Medical Co., Ltd.
  • Salter Labs
  • Fisher And Paykel Healthcare Limited
  • TNI Medical Ag
  • Mek-Ics Co., Ltd.
  • Flexicare Medical Limited
  • Vapotherm
  • Teleflex Incorporated
  • Resmed
  • Hamilton Medical Inc,
  • Get more information on this report

    Asia-Pacific High-Flow Nasal Cannula Regional Insights

    The regional scope of Asia-Pacific High-Flow Nasal Cannula refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-high-flow-nasal-cannula-market-geography.webp
    Get more information on this report

The List of Companies - Asia-Pacific High-Flow Nasal Cannula Market

The List of Companies - APAC High Flow Nasal Cannula Market

 

  1. Great Group Medical Co., Ltd.
  2. Salter Labs
  3. Fisher And Paykel Healthcare Limited
  4. TNI Medical Ag
  5. Mek-Ics Co., Ltd.
  6. Flexicare Medical Limited
  7. Vapotherm
  8. Teleflex Incorporated
  9. Resmed
  10. Hamilton Medical Inc,

 

Frequently Asked Questions
How big is the Asia-Pacific High-Flow Nasal Cannula Market?

The Asia-Pacific High-Flow Nasal Cannula Market is valued at US$ 951.53 Million in 2018, it is projected to reach US$ 2,536.52 Million by 2027.

What is the CAGR for Asia-Pacific High-Flow Nasal Cannula Market by (2019 - 2027)?

As per our report Asia-Pacific High-Flow Nasal Cannula Market, the market size is valued at US$ 951.53 Million in 2018, projecting it to reach US$ 2,536.52 Million by 2027. This translates to a CAGR of approximately 11.7% during the forecast period.

What segments are covered in this report?

The Asia-Pacific High-Flow Nasal Cannula Market report typically cover these key segments-

  • 组件 (空气氧气混合器, 鼻插管, 加热吸气回路, 主动加湿器)
  • 应用 (支气管扩张, 急性呼吸衰竭, 急性心力衰竭, 慢性阻塞性肺病)
  • 最终用户 (门诊护理中心, 医院和长期护理中心)
  • What is the historic period, base year, and forecast period taken for Asia-Pacific High-Flow Nasal Cannula Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia-Pacific High-Flow Nasal Cannula Market report:

  • Historic Period : 2016-2017
  • Base Year : 2018
  • Forecast Period : 2019-2027
  • Who are the major players in Asia-Pacific High-Flow Nasal Cannula Market?

    The Asia-Pacific High-Flow Nasal Cannula Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Great Group Medical Co., Ltd.
  • Salter Labs
  • Fisher And Paykel Healthcare Limited
  • TNI Medical Ag
  • Mek-Ics Co., Ltd.
  • Flexicare Medical Limited
  • Vapotherm
  • Teleflex Incorporated
  • Resmed
  • Hamilton Medical Inc,
  • Who should buy this report?

    The Asia-Pacific High-Flow Nasal Cannula Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia-Pacific High-Flow Nasal Cannula Market value chain can benefit from the information contained in a comprehensive market report.